KOLOA, Hawaii — Cataract surgeons may need to monitor patients with glaucoma more than the average cataract patient, including discussing vision expectations and future IOP management, according to a speaker here.“It is important to keep the IOP goal i…
Month: January 2023
Alivi Health Expands into Several States
MIAMI–(BUSINESS WIRE)–Alivi Health today announced the expansion of their Non-Emergency Transportation (NET) solution into several states. Alivi is actively providing services in 13 states, and has now expanded into New York, New Jersey, Pennsylvania…
‘Something needs to change’: ACP plans to streamline specialty referrals
The ACP has proposed a new process to streamline specialty referrals — a step that experts have called critical to fixing a massive issue in health care — but questions remain about the plan’s feasibility.The paper “lays out how a lack of care coordina…
Hydrogel Scaffold Makes a Living Electrode
A team of researchers at the Harvard Wyss Institute have developed a soft, hydrogel scaffold that can function as a living electrode for brain-computer interface applications. The researchers used electrically conductive materials and created a porous and flexible scaffold using a freeze-drying process. They then seeded the scaffold with human neural progenitor cells (NPCs) and […]
CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board
SHERBORN, Mass.–(BUSINESS WIRE)–CXL Ophthalmics announces that Jonathan Talamo, MD has been appointed as its new Chair of the Board of Directors.
Exegenesis Bio Announces FDA Clearance of Investigational New Drug (IND) Application for EXG102-031; A Novel Gene Therapy for the Treatment of neovascular Age-Related Macular Degeneration (nAMD)
PHILADELPHIA–(BUSINESS WIRE)– #biotechnology–Exegenesis Bio, a rapidly growing global gene therapy company is pleased to announce that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for EXG102-…
NTT Research to Host Upgrade 2023 Global Innovation Summit
SUNNYVALE, Calif.–(BUSINESS WIRE)– #TechforGood–NTT Research will hold Upgrade 2023, the NTT Research Summit, in-person on March 15-16, 2023, organized under the theme “Scaling the Future.”
Trefoil Therapeutics Announces First Patient Dosed in Phase 1 Study of TTHX1114 for Treatment of Corneal Epithelial Defects
SAN DIEGO–(BUSINESS WIRE)–Trefoil Therapeutics Announces First Patient Dosed in Phase 1 Study of TTHX1114 for Treatment of Corneal Epithelial Defects
VIDEO: Intraoperative OCT gives depth information useful for subretinal drug delivery
KOLOA, Hawaii — In this Healio Video Perspective from Retina 2023, Lejla Vajzovic, MD, FASRS, discusses updates in 3D intraoperative OCT in retinal surgery.“Intraoperative OCT will be the future in the sense that it will help us understand the depth in…
VIDEO: ViaLase’s femtosecond laser shows positive safety, efficacy data
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Shawn O’Neil of ViaLase discusses positive 24-month safety and efficacy data for the company’s noninvasive OCT-driven femtosecond laser for glaucoma treatment.The laser showed no …
VIDEO: Apellis nears PDUFA date for pegcetacoplan
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Cedric Francois, MD, PhD, CEO of Apellis, delivers an update on the company’s offerings, including the PDUFA date for the geographic atrophy treatment pegcetacoplan.“We look forwa…
Bausch + Lomb announces acquisition of AcuFocus
KOLOA, Hawaii — Bausch + Lomb has announced that an affiliate of the company has acquired AcuFocus.The announcement follows FDA approval of AcuFocus’ IC-8 Apthera small-aperture non-toric extended depth of focus IOL in July 2022.The IC-8 Apthera is ind…
Less is more when faced with posterior capsular rupture
KOLOA, Hawaii — Cataract surgeons need to be able to defend their decision to continue operating after posterior capsular rupture and to aggressively chase vitreous floaters, according to a panelist here.In a panel discussion at Hawaiian Eye 2023, Judy…
Macular thickness mapping detects hydroxychloroquine toxicity early, with specificity
KOLOA, Hawaii — Sequential macular thickness mapping can be used to detect retinal toxicity from hydroxychloroquine early and with specificity, according to a speaker here.A fundus or clinical exam, on the other hand, is not ideal, Robin A. Vora, MD, s…
Ultra-widefield imaging yields predictive data for diabetic retinopathy worsening
KOLOA, Hawaii — Ultra-widefield fluorescein angiography may enable more sensitive and specific methods to predict diabetic retinopathy worsening compared with standard FA, Paolo S. Silva, MD, said at Retina 2023.More than 80% of nonperfusion in diabeti…
VIDEO: Inside Private Equity blog addresses growth strategies for physicians of all specialties
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Allison Shuren, JD, MSN, discusses some of the topics and aims of Healio’s new Inside Private Equity blog series.“Arnold & Porter has been partnering with Healio to try to bring i…
Speaker shares various uses for hyaluronic acid fillers
KOLOA, Hawaii — It is helpful to use thicker filler products when dealing with thicker skin, according to a speaker here.“In thin skin, I use something with a cannula that is a little bit more forgiving,” Keith A. Marcus, MD, said at Hawaiian Eye 2023….
Treatment controversy among major challenges for central serous chorioretinopathy
KOLOA, Hawaii — Lack of a consensus classification, overlapping pathophysiologic explanations and controversy over treatment make central serous chorioretinopathy “scream inducing,” according to a speaker.“These patients often have systemic hypertensio…
Best Estimates Made for Hydroxychloroquine Retinopathy Risk
Hydroxychloroquine dosing and retinopathy risk have long been a concern with its use. A new, comprehensive study finds that retinopathy diagnosis with cumulative dosing is actually low. Medscape Medical News
Local, systemic therapies expand options for uveitis treatment
KOLOA, Hawaii — Local steroid therapy can be beneficial for less severe uveitis, short-term uveitis and uveitic macular edema, according to a speaker here.“There are lots of ways to now treat noninfectious uveitis and uveitic macular edema, both local …